Clinical Trials on Malignancies, Hematologic in Switzerland

Total 372 results

Novartis Pharmaceuticals

Completed

A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

Hematological Malignancies

Germany, Switzerland, France
Thomas Zilli
University Hospital, Geneva

Recruiting

Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI

Haematological Malignancy

Switzerland
University Hospital Inselspital, Berne

Completed

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies (LUNCH1)

Colitis | AML | Mucositis

Switzerland
EMD Serono

Terminated

A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies

Haematological Malignancies

Italy, United States, Switzerland, Belgium, Germany
Luzerner Kantonsspital

Recruiting

Prevalence of FID and QoL in Patients With Oncological and With Haematological Malignancies

Functional Iron Deficiency

Switzerland
Centre Hospitalier Universitaire Vaudois

Unknown

Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) (BIMI)

Hematologic Diseases | Hematologic Malignancy | Invasive Mold Infections | Breakthrough Invasive Mold Infections

Switzerland, Austria, Germany
Merck Sharp & Dohme LLC

Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors | Hematologic Malignancies

United States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
University Hospital, Basel, Switzerland
University of Basel; University Hospital, Zürich

Completed

Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation (PROVIVO)

Hematologic Neoplasms

Switzerland
University Hospital, Basel, Switzerland

Completed

Probability of Optimal Target Attainment of Amikacin in Patients With Febrile Neutropenia During Treatment for a Hematological Disorder

Febrile Neutropenia (FN)

Switzerland
Theusinger Oliver M.

Completed

Anemia in Orthopedic Surgery - Determination of Hb

Anemia

Switzerland
University Hospital Inselspital, Berne

Completed

Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients

Anemia

Switzerland
University Hospital, Basel, Switzerland

Completed

Internet and Social Media Use in Dermatology Patients

Dermatologic Diseases

Switzerland
Mundipharma Research Limited

Active, not recruiting

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

Multiple Myeloma | Hodgkin's Lymphoma | Hematological Malignancies | Cutaneous T Cell Lymphoma

France, United States, Netherlands, Spain, Switzerland, Germany, Italy
Centre Hospitalier Universitaire Vaudois

Completed

Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping

Transfusion Reaction

Switzerland
University of Zurich

Completed

Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients

Dermatologic Disease of Inpatients in Internal Medicine

Switzerland
University Hospital, Geneva

Completed

Ex-Vivo Reversion of Platelet Inhibition Induced by Prasugrel

Acquired Platelet Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Screening for Hemoglobinopathies in Pregnant Women

Hemoglobinopathies

Switzerland
University Hospital, Basel, Switzerland
Roche Pharma AG

Completed

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

Renal Anemia

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From Tef-injera in Women of Reproductive Age

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
Columbia University

Completed

Iron Interventions and Non-transferrin-bound Iron (NTBI) in Women (NTBIwomen)

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From GDS Capsules

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
DSM Nutritional Products, Inc.

Completed

Absorption, Stable Isotope Appearance and Non-transferrin-bound Iron (NTBI) Profile From NaFeEDTA and Ferrous Sulphate (SIA)

Iron Deficiency

Switzerland
University Hospital, Basel, Switzerland

Completed

Pregnancy Outcome in Women With an Iron Deficiency in the First Trimester

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Bioavailability From Encapsulated Ferrous Sulphate

Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From GDS Capsules II

Iron Deficiency

Switzerland
Cellestia Biotech AG

Terminated

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Breast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALL

United States, Spain, Korea, Republic of, Germany, France, Switzerland
Swiss Federal Institute of Technology

Completed

Measuring Erythrocyte Iron Incorporation From Different Dosing Regimens in Anemic Women

Iron Deficiency Anemia

Switzerland
Triemli Hospital
University of Zurich

Completed

Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm (SONALG)

Coagulation Disorder, Blood

Switzerland
Unilever R&D

Completed

Bioavailability of Iron From Savoury Food Product

Healthy | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
Zurich University of Applied Sciences

Enrolling by invitation

Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability (Study 2) (Sustironable2)

Iron-deficiency

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS

Acute Myeloid Leukemia | Myelodysplastic Syndromes

Switzerland
Swiss Federal Institute of Technology
Zurich University of Applied Sciences

Completed

Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability (Study 1) (Sustironable1)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Effect of Ovotransferrin and Lactoferrin on Iron Absorption From Ferrous Sulfate in Adult Women (OTf)

Iron-deficiency

Switzerland
Isabelle Herter-Aeberli
Burgerstein Vitamine

Completed

Determination of a Dose-dependent Effect of GOS on Iron Absorption, and Addition of Vitamin C (Fe_GOS_2)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology
Burgerstein Vitamine

Completed

Effect of Prebiotics on Iron Absorption in Women With Low Iron Stores (Fe_GOS_1)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Unknown

Iron Absorption From Fortified Extruded Rice Using Different Extruding Temperatures.

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Effect of Different Prebiotics on Iron Absorption From High Dose Iron Supplements

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Unknown

Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From Encapsulated Iron Sulphate in Microspheres

Iron-deficiency

Switzerland
Philipp Stein

Completed

Diagnostic of Iron Deficiency by Means of Non Invasive Measurement of Zink Protoporphyrin IX (ZnPP)

Iron-deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Optimization of Bioavailability From Iron Supplements: Study 1

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

The Optimization of Bioavailability From Iron Supplements: Study 2

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology
University Hospital, Zürich; ETH Zurich

Completed

Using Stable Iron Isotopic Techniques and Serum Hepcidin Profiles to Optimize Iron Supplementation

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
Swiss Federal Institute of Technology

Completed

Iron Absorption From Rice Fortified With Ferric Pyrophosphate

Anemia | Iron Deficiency Anemia | Iron Deficiency

Switzerland
University Hospital, Geneva

Completed

Standardisation of Investigations of Mild Bleeding Disorders (MBD)

Hemorrhagic Disorders

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes

Switzerland
University of Zurich

Completed

Effectiveness of Low-dose Iron Treatment in Non-anaemic Iron-deficient Women

Iron Deficiency (Without Anemia)

Switzerland
Pierre-Alexandre Krayenbuehl

Completed

Plasma Hepcidin Response to Differently Dosed Iron Supplements

Iron Deficiency (Without Anemia)

Switzerland
Dr Yan Beauverd

Completed

Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure (MPNClot)

Polycythemia Vera | Thrombocythemia, Essential

Switzerland, United Kingdom
University Hospital Inselspital, Berne

Completed

Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy

Febrile Neutropenia | Pediatric Cancer | Oncology | Chemotherapy-induced Neutropenia

Switzerland

Clinical Trials on Malignancies, Hematologic in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations